Skip to content
LexBuild

New Animal Drugs For Use in Animal Feeds; Change of Sponsor

---
identifier: "/us/fr/E7-21059"
source: "fr"
legal_status: "authoritative_unofficial"
title: "New Animal Drugs For Use in Animal Feeds; Change of Sponsor"
title_number: 0
title_name: "Federal Register"
section_number: "E7-21059"
section_name: "New Animal Drugs For Use in Animal Feeds; Change of Sponsor"
positive_law: false
currency: "2007-10-25"
last_updated: "2007-10-25"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E7-21059"
document_type: "rule"
publication_date: "2007-10-25"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 558"
fr_citation: "72 FR 60551"
fr_volume: 72
effective_date: "2007-10-25"
fr_action: "Final rule."
---

#  [Amended]

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Final rule.

**SUMMARY:**

The Food and Drug Administration (FDA) is amending the  animal drug regulations to reflect a change of sponsor for seven approved new animal drug applications (NADAs) from Schering-Plough Animal Health Corp. to Huvepharma AD.

**DATES:**

This rule is effective October 25, 2007.

**FOR FURTHER INFORMATION CONTACT:**

David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail: *[email protected]* .

**SUPPLEMENTARY INFORMATION:**

Schering-Plough Animal Health Corp., 556 Morris Ave., Summit NJ 07901, has informed FDA that it has transferred ownership of, and all rights and interest in, the following seven approved NADAs to Huvepharma AD, 33 James Boucher Blvd., Sophia 1407, Bulgaria:

| Application No. | Trade name(s) |
| --- | --- |
| 140-951 | CLINICOX (diclazuril) Type A Medicated Article |
| 141-090 | CLINICOX / STAFAC |
| 141-153 | CLINICOX / BMD |
| 141-158 | CLINICOX / FLAVOMYCIN |
| 141-190 | CLINICOX / BMD / 3-NITRO |
| 141-194 | CLINICOX / BMD |
| 141-195 | CLINICOX / FLAVOMYCIN |

Accordingly, the agency is amending the regulations in 21 CFR 558.198 to reflect the transfer of ownership.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

**List of Subjects in 21 CFR Part 558**

Animal drugs, Animal feeds.

**21 CFR Part 558**

Therefore, under the Federal Food, Drug and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:

**PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS**

**21 CFR Part 558**

1. The authority citation for 21 CFR part 558 continues to read as follows:

**Authority:**

21 U.S.C. 360b, 371.

**21 CFR Part 558**

§ 558.198

2. In § 558.198, in paragraph (b), remove “000061” and in its place add “016592”; and in the tables in paragraphs (d)(1) and (d)(2), in the “Sponsor” column, remove “000061” wherever it occurs and in its place add “016592”.

Dated: October 17, 2007.

Bernadette Dunham,

Deputy Director, Center for Veterinary Medicine.